Compare FET & OFIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FET | OFIX |
|---|---|---|
| Founded | 2005 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 514.7M | 473.3M |
| IPO Year | 2007 | 1998 |
| Metric | FET | OFIX |
|---|---|---|
| Price | $59.28 | $12.76 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $17.25 |
| AVG Volume (30 Days) | 162.2K | ★ 231.3K |
| Earning Date | 04-30-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 92.64 | 29.39 |
| EPS | ★ N/A | N/A |
| Revenue | $791,474,000.00 | ★ $822,312,000.00 |
| Revenue This Year | $7.35 | $6.10 |
| Revenue Next Year | $6.95 | $6.24 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 2.85 |
| 52 Week Low | $13.55 | $10.25 |
| 52 Week High | $63.58 | $16.99 |
| Indicator | FET | OFIX |
|---|---|---|
| Relative Strength Index (RSI) | 52.10 | 60.70 |
| Support Level | $54.52 | $12.33 |
| Resistance Level | $63.24 | $16.38 |
| Average True Range (ATR) | 2.69 | 0.41 |
| MACD | -0.21 | 0.19 |
| Stochastic Oscillator | 37.95 | 85.48 |
Forum Energy Technologies Inc is a products company, serving the oil, natural gas, industrial and renewable energy industries. The company designs, manufactures, and distributes products and engages in aftermarket parts supply and services that complement its product offering. Its products include engineered capital equipment, as well as products that are consumed in the drilling, well construction, production, and transportation of oil and natural gas. It operates in two reporting segments, namely Drilling and Completions and Artificial Lift and Downhole. Revenue largely comes from Artificial Lift and Downhole segment.
Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two reportable segments: Global Spine and Global Limb Reconstruction. The Global Spine segment offers bone growth therapies, spinal implants, biologics, and enabling technologies used in spinal procedures. The Global Limb Reconstruction segment provides products and solutions for limb deformity correction, limb lengthening, fracture management, and limb preservation, supported by digital technologies. It generates the majority of its revenue from the Global Spine segment.